Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001104659-20-122032

Options or other derivatives

  • Director acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lefenfeld Michael · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-11-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +7,500 $11.38 2030-11-03 7,500 7,500 D
Loading xslF345X03/a4.xml…